SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-008230
Filing Date
2024-01-30
Accepted
2024-01-30 16:05:22
Documents
17
Period of Report
2024-01-25
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm244525d1_8k.htm   iXBRL 8-K 31025
2 EXHIBIT 99.1 tm244525d1_ex99-1.htm EX-99.1 9042
6 GRAPHIC tm244525d1_ex99-1img001.jpg GRAPHIC 3962
7 GRAPHIC tm244525d1_ex99-1img002.jpg GRAPHIC 2553
  Complete submission text file 0001104659-24-008230.txt   228506

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sgmt-20240125.xsd EX-101.SCH 3012
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE sgmt-20240125_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sgmt-20240125_pre.xml EX-101.PRE 22357
18 EXTRACTED XBRL INSTANCE DOCUMENT tm244525d1_8k_htm.xml XML 3743
Mailing Address 155 BOVET RD., SUITE 303 SAN MATEO CA 94402
Business Address 155 BOVET RD., SUITE 303 SAN MATEO CA 94402 (650) 561-8600
Sagimet Biosciences Inc. (Filer) CIK: 0001400118 (see all company filings)

IRS No.: 205991472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41742 | Film No.: 24578167
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)